Vanda Pharmaceuticals Inc.

VNDA Nasdaq SEC CIK 1347178
Follow Vanda Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $69.8M +24.1% vs same quarter last year
Net income −$22.6M +0.1% vs same quarter last year
EPS, diluted −$0.37 +2.6% vs same quarter last year
Operating cash flow −$28.4M +10.1% vs same quarter last year
Revenue by quarter
$53.2M
$50M
$52.6M
$56.3M
$57.2M
$51.7M
$50.5M
$69.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$400M−$200M$0$200M$400MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$216.1M−$220.5M
FY24$198.8M−$18.9M
FY23$192.6M$2.5M
FY22$254.4M$6.3M
FY21$268.7M$33.2M
FY20$248.2M$23.3M
FY19$227.2M$115.6M
FY18$193.1M$25.2M
FY17$165.1M−$15.6M
FY16$146M−$18M
FY15$109.9M−$39.9M
FY14$50.2M$20.2M
FY13$33.9M−$21.1M
FY12$32.7M−$28.6M
FY11$31.3M−$9.8M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−200%−100%0%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25-−70%−102%
FY24-−20.5%−9.5%
FY23-−7.2%1.3%
FY22-2.5%2.5%
FY21-15.7%12.4%
FY20-11%9.4%
FY19-10%50.9%
FY18-11.3%13.1%
FY17-−10.2%−9.4%
FY16-−12.7%−12.3%
FY1578.7%−36.6%−36.3%
FY1496.8%40%40.2%
FY13-−62.6%−62.1%
FY1299.6%−89.2%−87.4%
FY11-−34.2%−31.3%
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0$50M$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$110.4M
FY24−$16.2M
FY23$12.4M
FY22$31.3M
FY21$63.7M
FY20$50M
FY19$44.9M
FY18$29.6M
FY17−$3.6M
FY16−$9.5M
FY15$9.9M
FY14−$82.3M
FY13−$39.8M
FY12−$46.9M
FY11−$28.7M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Vanda Pharmaceuticals
  • Healthcare median
−150%−100%−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearVanda PharmaceuticalsHealthcare median
FY25−102%−30.6%
FY24−9.5%−47%
FY231.3%−58%
FY222.5%−80.4%
FY2112.4%−71.8%
FY209.4%−62.2%
FY1950.9%−46.2%
FY1813.1%−49.6%
FY17−9.4%−45.9%
FY16−12.3%−36%
FY15−36.3%−37.8%
FY1440.2%−35.5%
FY13−62.1%−37.1%
FY12−87.4%−29.1%
FY11−31.3%−27.9%